KSCP
APFCP
SIUCP-ETS
Previous issues
- Page Path
- HOME > Browse Articles > Previous issues
- Volume 31(3); June 2015
-
- Clinical Implication of Colorectal Cancer Stem Cells: Still Has a Long Way to Go
- Hungdai Kim
- Ann Coloproctol. 2015;31(3):79-80. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.79
- 3,071 View
- 27 Download
- 1 Web of Science
- 1 Citations
- ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
- Moo-Jun Baek
- Ann Coloproctol. 2015;31(3):81-81. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.81
- 2,385 View
- 32 Download
- 1 Web of Science
- 1 Citations
- Stoma Creation After Surgery for Rectal Cancer: Temporary or Permanent?
- Jung Wook Huh
- Ann Coloproctol. 2015;31(3):82-82. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.82
- 2,562 View
- 32 Download
- 1 Web of Science
- 2 Citations
-
PDF -
Citations
Citations to this article as recorded by
- Temporary Stomas after Rectal Cancer Resection; Predilection of Being Permanent and Predictors of Complications?
Islam H. Metwally, Mohamed Abdelkhalek, Mohammad Zuhdy, Saleh S. Elbalka
Journal of Coloproctology.2023; 43(03): e191. CrossRef - Colorectal cancer in Taiwan: A case‐control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment
Ting‐Yu Chiang, Chao‐Hui Wang, Yu‐Fen Lin, Jeng‐Fu You, Jinn‐Shiun Chen, Shu‐Ching Chen
Journal of Advanced Nursing.2018; 74(2): 395. CrossRef
- Temporary Stomas after Rectal Cancer Resection; Predilection of Being Permanent and Predictors of Complications?
- Aluminum Potassium Sulfate and Tannic Acid - A New Option for the Treatment of Grade 3 Hemorrhoids
- Yong Hee Hwang
- Ann Coloproctol. 2015;31(3):83-83. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.83
- 2,700 View
- 39 Download
- Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
- Injae Hong, Seong Woo Hong, Yeo Goo Chang, Woo Yong Lee, Byungmo Lee, Yun Kyung Kang, You Sun Kim, In Wook Paik, Hyucksang Lee
- Ann Coloproctol. 2015;31(3):84-91. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.84
- 4,007 View
- 80 Download
- 37 Web of Science
- 29 Citations
-
Abstract
PDF Purpose The aim of this study was to assess the expressions of CD44 and CD133 in colorectal cancer tissue by using immunohistochemical staining and to analyze the clinical significance of the expressions related to other clinicopathological data and survival results.
Methods One hundred sixty-two patients with a biopsy-proven colorectal adenocarcinoma who were operated on between January 1998 and August 2004 were enrolled in this study. Immunohistochemical staining for CD44 and CD133 was performed on primary colorectal cancer tissue, metastatic lymph nodes, and synchronous and metachronous metastatic tumor tissues if available.
Results CD44 expression was stronger in the primary tumor than in metastatic lymph nodes (P < 0.001), and CD133 expression tended to be stronger in primary tumor than in metastatic lymph nodes (P = 0.057). No significant correlation was found between the CD44 and the CD133 expressions. The cases with recurrence showed low expression of CD44 (P = 0.017). CD133 expression was lower in cases with elevated CA 19-9 serum levels (P = 0.028) and advanced T stage (P = 0.038). Multivariate analysis proved that low expression of CD44 was an independent prognosis factor for short disease-free survival (P = 0.028).
Conclusion Low CD44 expression was correlated with increased tumor recurrence and short disease-free survival, and low CD133 expression was associated with advanced tumor stage. We suggest that further studies be performed to evaluate whether the immunohistochemical method for determining the CD44 and the CD133 expressions is appropriate for exploring cancer stem-cell biology in patients with colorectal cancer.
-
Citations
Citations to this article as recorded by- Reduction-responsive and tumor-targeted polyprodrug nanocarriers for targeting therapy of hepatocellular carcinoma
Wei Shi, Xiaoqing Xu, Jinyuan Tian, Ziyi Zhang, Zhanjun Liu
New Journal of Chemistry.2024; 48(9): 3793. CrossRef - CD44: A New Prognostic Marker in Colorectal Cancer?
Pina Ziranu, Andrea Pretta, Valentina Aimola, Flaviana Cau, Stefano Mariani, Alessandra Pia D’Agata, Claudia Codipietro, Daiana Rizzo, Veronica Dell’Utri, Giorgia Sanna, Giusy Moledda, Andrea Cadoni, Eleonora Lai, Marco Puzzoni, Valeria Pusceddu, Massimo
Cancers.2024; 16(8): 1569. CrossRef - The RNA-Binding Proteins OAS1, ZFP36L2, and DHX58 Are Involved in the Regulation of CD44 mRNA Splicing in Colorectal Cancer Cells
V. O. Novosad, D. V. Maltseva
Bulletin of Experimental Biology and Medicine.2023; 175(1): 144. CrossRef - Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
Sweta Suman, Subhransu Kumar Hota, Pranati Misra, Nageswar Sahu, Subrat Sahu
Cureus.2023;[Epub] CrossRef - Cancer stem cells: An overview of the pathophysiological and prognostic roles in colorectal cancer
Mehran Pashirzad, Thozhukat Sathyapalan, Afsana Sheikh, Prashant Kesharwani, Amirhossein Sahebkar
Process Biochemistry.2022; 115: 19. CrossRef - The presentation and regulation of the IL-8 network in the epithelial cancer stem-like cell niche in patients with colorectal cancer
Guanglin Cui, Gui Li, Zhigang Pang, Jon Florholmen, Rasmus Goll
Biomedicine & Pharmacotherapy.2022; 152: 113252. CrossRef - Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
Hassan Ehteram, Fatemeh Aslanbeigi, Ebrahim Ghoochani Khorasani, Mohammad Tolouee, Hamed Haddad Kashani
Oncology and Therapy.2022; 10(2): 451. CrossRef - Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications
Guanglin Cui, Ziqi Wang, Hanzhe Liu, Zhigang Pang
Frontiers in Immunology.2022;[Epub] CrossRef - Evaluation and Clinicopathological Correlation of CD44 in Colorectal Adenoma with Low/High-Grade Dysplasia and Carcinoma
Himanshi Bhanu, Ruchi Mittal, Sarojini Raman
Clinical Cancer Investigation Journal.2022; 11(6): 9. CrossRef - The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan
Yuan-Chang Dai, Chuan-Yin Fang, Hsin-Yi Yang, Yi-Jun Jian, Shou-Chieh Wang, Yi-Wen Liu, Frédéric André
PLOS ONE.2021; 16(7): e0254000. CrossRef - Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers
Melanie M. Ivancic, Bryant W. Megna, Yuriy Sverchkov, Mark Craven, Mark Reichelderfer, Perry J. Pickhardt, Michael R. Sussman, Gregory D. Kennedy
Journal of Surgical Research.2020; 246: 160. CrossRef - Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases
Jon Danel Solano-Iturri, Maider Beitia, Peio Errarte, Julio Calvete-Candenas, María C. Etxezarraga, Alberto Loizate, Enrique Echevarria, Iker Badiola, Gorka Larrinaga
Aging.2020; 12(11): 10337. CrossRef - The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma
Salem Y. Mohamed, Randa Mohamed Kaf, Mona Mostafa Ahmed, Amira Elwan, Hassan R Ashour, Amr Ibrahim
Journal of Gastrointestinal Cancer.2019; 50(4): 824. CrossRef - Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
Gui-Min Wen, Fei-Fei Mou, Wei Hou, Dan Wang, Pu Xia
Stem Cell Reviews and Reports.2019; 15(1): 23. CrossRef - The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
Zhenpeng Wang, Yufei Tang, Lei Xie, Aiping Huang, Chunchun Xue, Zhen Gu, Kaiqiang Wang, Shaoqi Zong
Frontiers in Oncology.2019;[Epub] CrossRef - Modulation of CD44, EGFR and RAC Pathway Genes (WAVE Complex) in Epithelial Cancers
Pranathi Tata, Piyush Gondaliya, Aditya Sunkaria, Akshay Srivastava, Kiran Kalia
Current Pharmaceutical Design.2019; 25(8): 833. CrossRef - CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients
Rongyong Huang, Dan Mo, Junrong Wu, Huaying Ai, Yiping Lu
Medicine.2018; 97(23): e10446. CrossRef - DNA mismatch repair and CD133-marked cancer stem cells in colorectal carcinoma
Phaik-Leng Cheah, Jing Li, Lai-Meng Looi, Kean-Hooi Teoh, Diana Bee-Lan Ong, Mark J. Arends
PeerJ.2018; 6: e5530. CrossRef - CD133 and CD44 as cancer stem cell markers in bladder carcinoma
Rania ES. Wasfy, Dina M. El-Guindy
Egyptian Journal of Pathology.2017; 37(1): 204. CrossRef - Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance
Ji Eun Choi, Jun Sang Bae, Myoung Jae Kang, Myoung Ja Chung, Kyu Yun Jang, Ho Sung Park, Woo Sung Moon
Oncology Reports.2017; 38(3): 1695. CrossRef - Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells
Natasha Hodgkinson, Cherie A Kruger, Heidi Abrahamse
Tumor Biology.2017; 39(10): 101042831773469. CrossRef - Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis
Zhan Yu, Zhen Chen, Jian Wu, Zhong Li, Yugang Wu, Surinder K. Batra
PLOS ONE.2017; 12(11): e0188139. CrossRef - Temporal and spatial changes of cells positive for stem-like markers in different compartments and stages of human colorectal adenoma-carcinoma sequence
Guanglin Cui, Gang Xu, Li Zhu, Zhigang Pang, Wei Zheng, Zhenfeng Li, Aping Yuan
Oncotarget.2017; 8(28): 45311. CrossRef - A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
Rabia Bilge Özgül Özdemir, Alper Tunga Özdemir, Fatih Oltulu, Kamile Kurt, Gürkan Yiğittürk, Cengiz Kırmaz
Annals of Diagnostic Pathology.2016; 25: 60. CrossRef - Implications of OCT4 in breast carcinoma from initiation to lymph node metastasis
Hoda H. Abou Gabal, Riham M. Abu-Zeid, Maissa N. El-Maraghy
Egyptian Journal of Pathology.2016; 36(2): 194. CrossRef - CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
Yang Zhao, Jing Peng, Enlong Zhang, Ning Jiang, Jiang Li, Qi Zhang, Xuening Zhang, Yuanjie Niu
Oncotarget.2016; 7(9): 10023. CrossRef - Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
Pu Xia, Xiao-Yan Xu
Oncotarget.2016; 7(29): 45538. CrossRef - Clinical Implication of Colorectal Cancer Stem Cells: Still Has a Long Way to Go
Hungdai Kim
Annals of Coloproctology.2015; 31(3): 79. CrossRef - Advances and perspectives of colorectal cancer stem cell vaccine
Mei Guo, Jun Dou
Biomedicine & Pharmacotherapy.2015; 76: 107. CrossRef
- Reduction-responsive and tumor-targeted polyprodrug nanocarriers for targeting therapy of hepatocellular carcinoma
- ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
- Chee Young Kim, Sang Hyuk Seo, Min Sung An, Kwang Hee Kim, Ki Beom Bae, Jin Won Hwang, Ji Hyun Kim, Bo Mi Kim, Mi Seon Kang, Min Kyung Oh, Kwan Hee Hong
- Ann Coloproctol. 2015;31(3):92-97. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.92
- 3,487 View
- 40 Download
- 7 Web of Science
- 6 Citations
-
Abstract
PDF
Purpose The purpose of this study was to identify the excision repair cross-complementation group 1 (ERCC1) as a predictive marker for FOLFOX adjuvant chemotherapy in stages II and III colon cancer patients.
Methods A total of 166 high risk stages II and III colon cancer patients were retrospectively enrolled in this study, and data were collected prospectively. They underwent a curative resection followed by FOLFOX4 adjuvant chemotherapy. We analyzed ERCC1 expression in the primary colon tumor by using immunohistochemical staining. The oncological outcomes included the 5-year disease-free survival (DFS) rate. The DFS was analyzed by using the Kaplan-Meier method with the log-rank test. A Cox proportional hazard model was used for the prognostic analysis.
Results ERCC1-positive expression was statistically significant in the older patients (P = 0.032). In the multivariate analysis, the prognostic factors for DFS were female sex (P = 0.016), N stage (P = 0.009), and postoperative carcinoembryonic antigen level (P = 0.001), but ERCC1 expression was not a statistically significant prognostic factor for DFS in the univariate analysis (P = 0.397). The 5-year DFS rate was not significantly associated with the ERCC1 expression in all patients (P = 0.396) or with stage III disease (P = 0.582).
Conclusion We found that ERCC1 expression was not significantly correlated with the 5-year DFS as reflected by the oncologic outcomes in patients with high-risk stages II and III colon cancer treated with FOLFOX adjuvant chemotherapy.
-
Citations
Citations to this article as recorded by- ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia
Dhouha Jamai, Raja Gargouri, Boulbaba Selmi, Abdelmajid Khabir
Genes.2023; 14(7): 1467. CrossRef - EXPRESSION OF NUCLEOTIDE EXCISION REPAIR PROTEIN ERCC1 IN TUMOR TISSUE AS A PROGNOSTIC FACTOR IN COLORECTAL CANCER
Irina Aleksandrovna Bogomolova, Dinara Rishatovna Dolgova, Inna Ivanovna Antoneeva, Ekaterina Gennad'evna Parmenova, Il'seya Rinatovna Myagdieva, Mark Alekseevich Urevskiy
Ulyanovsk Medico-biological Journal.2023; (3): 167. CrossRef - ERCC1, PARP-1, and AQP1 as predictive biomarkers in colon cancer patients receiving adjuvant chemotherapy
Aziza E. Abdelrahman, Doaa Abdelaziz Ibrahim, Ahmed El-Azony, Ahmed A. Alnagar, Amr Ibrahim
Cancer Biomarkers.2020; 27(2): 251. CrossRef - Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity
Kai M. Brown, Aiqun Xue, Sohel M. Julovi, Anthony J. Gill, Nick Pavlakis, Jaswinder S. Samra, Ross C. Smith, Thomas J. Hugh
Journal of Surgical Research.2018; 227: 158. CrossRef - Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options
Daniela Rodrigues, Adhemar Longatto-Filho, Sandra F. Martins
BioMed Research International.2016; 2016: 1. CrossRef - ERCC1 and the Prognosis for Patients With Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
Moo-Jun Baek
Annals of Coloproctology.2015; 31(3): 81. CrossRef
- ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia
- Multivariate Analysis of Risk Factors Associated With the Nonreversal Ileostomy Following Sphincter-Preserving Surgery for Rectal Cancer
- Young Ah Kim, Gil Jae Lee, Sung Won Park, Won-Suk Lee, Jeong-Heum Baek
- Ann Coloproctol. 2015;31(3):98-102. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.98
- 3,891 View
- 33 Download
- 20 Web of Science
- 20 Citations
-
Abstract
PDF
Purpose A loop ileostomy is used to protect an anastomosis after anal sphincter-preserving surgery, especially in patients with low rectal cancer, but little information is available concerning risk factors associated with a nonreversal ileostomy. The purpose of this study was to identify risk factors of ileostomy nonreversibility after a sphincter-saving resection for rectal cancer.
Methods Six hundred seventy-nine (679) patients with rectal cancer who underwent sphincter-preserving surgery between January 2004 and December 2011 were evaluated retrospectively. Of the 679, 135 (19.9%) underwent a defunctioning loop ileostomy of temporary intent, and these patients were divided into two groups, that is, a reversal group (RG, 112 patients) and a nonreversal group (NRG, 23 patients) according to the reversibility of the ileostomy.
Results In 23 of the 135 rectal cancer patients (17.0%) that underwent a diverting ileostomy, stoma reversal was not possible for the following reasons; stage IV rectal cancer (11, 47.8%), poor tone of the anal sphincter (4, 17.4%), local recurrence (2, 8.7%), anastomotic leakage (1, 4.3%), radiation proctitis (1, 4.3%), and patient refusal (4, 17.4%). The independent risk factors of the nonreversal group were anastomotic leakage or fistula, stage IV cancer, local recurrence, and comorbidity.
Conclusion Postoperative complications such as anastomotic leakage or fistula, advanced primary disease (stage IV), local recurrence and comorbidity were identified as risk factors of a nonreversal ileostomy. These factors should be considered when drafting prudential guidelines for ileostomy closure.
-
Citations
Citations to this article as recorded by- Preoperative risk factors and cumulative incidence of temporary ileostomy non-closure after sphincter-preserving surgery for rectal cancer: a meta-analysis
Fan He, Chenglin Tang, Fuyu Yang, Defei Chen, Junjie Xiong, Yu Zou, Dongqin Zhao, Kun Qian
World Journal of Surgical Oncology.2024;[Epub] CrossRef - SafeHeal Colovac Colorectal Anastomosis Protection Device evaluation (SAFE‐2) pivotal study: an international randomized controlled study to evaluate the safety and effectiveness of the Colovac Colorectal Anastomosis Protection Device
Elisabeth Hain, Jérémie H. Lefèvre, Alison Ricardo, Sang Lee, Karen Zaghiyan, Elisabeth McLemore, Danny Sherwinter, Rebecca Rhee, Matthew Wilson, Joseph Martz, Justin Maykel, John Marks, Jorge Marcet, Philippe Rouanet, Leon Maggiori, Niels Komen, Nicolas
Colorectal Disease.2024; 26(6): 1271. CrossRef - Early vs. Late Stoma Reversal After Open Low Anterior Resection Post-Neoadjuvant Chemoradiotherapy
Fahad Bin Abdul Majeed, Madhu Muralee, Chandramohan
Indian Journal of Surgical Oncology.2024;[Epub] CrossRef - Determination of Factors Related to the Reversal and Perioperative Outcomes of Defunctioning Ileostomies in Patients Undergoing Rectal Cancer Surgery: A Regression Analysis Model
Ioannis Baloyiannis, Konstantinos Perivoliotis, Ioannis Mamaloudis, Effrosyni Bompou, Chamaidi Sarakatsianou, George Tzovaras
Journal of Gastrointestinal Cancer.2023; 54(3): 782. CrossRef - Effect of 3D Animation Combined with Teach-Back Health Education on Pelvic Floor Muscle Training in LARS Patients: A Randomized Controlled Trial
Jingjing Ye, Xiaoyan Xu, Shengnian Lu, Xiaojun Xu, Hanmei Liu, Mingxian Luo, Jiamei Zhou, Lianhong Wang, Yongmei Zhang, Nabeel Al-Yateem
Journal of Nursing Management.2023; 2023: 1. CrossRef - Risk factors and incidence of non-closure stoma in patients with anterior resection of rectal cancer with temporary stoma: A systematic review and meta-analysis
Lu Zhou, Zuming Qin, Ling Wang
European Journal of Surgical Oncology.2023; 49(12): 107120. CrossRef - Temporary Stomas after Rectal Cancer Resection; Predilection of Being Permanent and Predictors of Complications?
Islam H. Metwally, Mohamed Abdelkhalek, Mohammad Zuhdy, Saleh S. Elbalka
Journal of Coloproctology.2023; 43(03): e191. CrossRef - The safety of early versus late ileostomy reversal after low anterior rectal resection: a retrospective study in 47 patients
Ian Fukudome, Hiromichi Maeda, Ken Okamoto, Hajime Kuroiwa, Sachi Yamaguchi, Kazune Fujisawa, Mai Shiga, Ken Dabanaka, Michiya Kobayashi, Tsutomu Namikawa, Kazuhiro Hanazaki
Patient Safety in Surgery.2021;[Epub] CrossRef - Risk factors associated with non-closure of defunctioning stoma in patients with rectal cancer: univariate and multivariate analysis
M.V. Alekseev, Yu.A. Shelygin, E.G. Rybakov
Khirurgiya. Zhurnal im. N.I. Pirogova.2021; (2): 40. CrossRef - Morbidity and costs of diverting ileostomy in transanal total mesorectal excision with primary anastomosis for rectal cancer
J. C. Hol, F. Bakker, N. T. van Heek, G. M. de Jong, F. M. Kruyt, C. Sietses
Techniques in Coloproctology.2021; 25(10): 1133. CrossRef - Assessment of defecation function after sphincter-saving resection for mid to low rectal cancer: A cross-sectional study
Bao-Jia Luo, Mei-Chun Zheng, Yang Xia, Zhu Ying, Jian-Hong Peng, Li-Ren Li, Zhi-Zhong Pan, Hui-Ying Qin
European Journal of Oncology Nursing.2021; 55: 102059. CrossRef - Predictors of permanent stoma creation in patients with mid or low rectal cancer: results of a multicentre cohort study with preoperative evaluation of anal function
S. Kim, M. H. Kim, J. H. Oh, S.‐Y. Jeong, K. J. Park, H.‐K. Oh, D.‐W. Kim, S.‐B. Kang
Colorectal Disease.2020; 22(4): 399. CrossRef - The fate of preserved sphincter in rectal cancer patients
Ri Na Yoo, Gun Kim, Bong-Hyeon Kye, Hyeon-Min Cho, HyungJin Kim
International Journal of Colorectal Disease.2018; 33(6): 745. CrossRef - Patients With Temporary Ostomies
Mohammed Iyoob Mohammed Ilyas, David A. Haggstrom, Melinda A. Maggard-Gibbons, Christopher S. Wendel, Susan Rawl, Christian Max Schmidt, Clifford Y. Ko, Robert S. Krouse
Journal of Wound, Ostomy & Continence Nursing.2018; 45(6): 510. CrossRef - Risk Factors Associated With Nonclosure of Defunctioning Stomas After Sphincter-Preserving Low Anterior Resection of Rectal Cancer: A Meta-Analysis
Xin Zhou, Bingyan Wang, Fei Li, Jilian Wang, Wei Fu
Diseases of the Colon & Rectum.2017; 60(5): 544. CrossRef - Use of a nomogram to predict the closure rate of diverting ileostomy after low anterior resection: A retrospective cohort study
Shinya Abe, Kazushige Kawai, Hiroaki Nozawa, Keisuke Hata, Tomomichi Kiyomatsu, Toshiaki Tanaka, Takeshi Nishikawa, Kensuke Otani, Kazuhito Sasaki, Manabu Kaneko, Koji Murono, Shigenobu Emoto, Toshiaki Watanabe
International Journal of Surgery.2017; 47: 83. CrossRef - Fortune of temporary ileostomies in patients treated with laparoscopic low anterior resection for rectal cancer
Mustafa Haksal, Nuri Okkabaz, Ali Emre Atici, Osman Civil, Yasar Ozdenkaya, Ayhan Erdemir, Nihat Aksakal, Mustafa Oncel
Annals of Surgical Treatment and Research.2017; 92(1): 35. CrossRef - Current Status of the Watch-and-Wait Policy for Patients with Complete Clinical Response Following Neoadjuvant Chemoradiation in Rectal Cancer
Rob Glynne-Jones, Rob Hughes
Current Colorectal Cancer Reports.2017; 13(1): 17. CrossRef - Early closure of defunctioning stoma increases complications related to stoma closure after concurrent chemoradiotherapy and low anterior resection in patients with rectal cancer
Tzu-Chieh Yin, Hsiang-Lin Tsai, Ping-Fu Yang, Wei-Chih Su, Cheng-Jen Ma, Ching-Wen Huang, Ming-Yii Huang, Chun-Ming Huang, Jaw-Yuan Wang
World Journal of Surgical Oncology.2017;[Epub] CrossRef - Stoma Creation After Surgery for Rectal Cancer: Temporary or Permanent?
Jung Wook Huh
Annals of Coloproctology.2015; 31(3): 82. CrossRef
- Preoperative risk factors and cumulative incidence of temporary ileostomy non-closure after sphincter-preserving surgery for rectal cancer: a meta-analysis
- Comparison of Injection Sclerotherapy Between 5% Phenol in Almond Oil and Aluminum Potassium Sulfate and Tannic Acid for Grade 3 Hemorrhoids
- Takaaki Yano, Kenji Yano
- Ann Coloproctol. 2015;31(3):103-105. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.103
- 4,420 View
- 55 Download
- 19 Web of Science
- 19 Citations
-
Abstract
PDF
Purpose Injection sclerotherapy for hemorrhoids has been performed for many years. Currently, 5% phenol in almond oil (PAO) and aluminum potassium sulfate and tannic acid (ALTA) are used as the agents. The purpose of this study was to compare the efficacy of the two agents.
Methods A retrospective study was conducted involving 135 patients who underwent injection therapy for grade 3 hemorrhoids for the first time between 2013 and 2014 (PAO, 55 patients; ALTA, 80 patients). The efficacy was established as the proportion (%) of patients without symptoms such as hemorrhage and prolapse one year after treatment. We investigated four factors—sex, age, number of hemorrhoids, and agent—that might have an influence on the efficacy.
Results The efficacies of ALTA and PAO one year after treatment were 75% and 20%, respectively. Only the agent was a significant independent factor (P < 0.01).
Conclusion The results suggest that ALTA is markedly more useful than PAO for injection sclerotherapy for grade 3 hemorrhoids.
-
Citations
Citations to this article as recorded by- Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis
G. Gallo, A. Picciariello, C. Armellin, E. Lori, G. Tomasicchio, G. L. Di Tanna, G. A. Santoro, M. Alharbi, S. Sorrenti, U. Grossi
Techniques in Coloproctology.2024;[Epub] CrossRef - Aluminum potassium sulfate and tannic acid (ALTA) sclerotherapy for hemorrhoidal disease: a systematic review and meta-analysis
Vasiliki Manaki, Vangelis Bontinis, Alkis Bontinis, Argirios Giannopoulos, Ioannis Kontes, Angeliki Chorti, Kiriakos Ktenidis
Acta Chirurgica Belgica.2024; 124(4): 253. CrossRef - The Italian Unitary Society of Colon-Proctology (Società Italiana Unitaria di Colonproctologia) guidelines for the management of acute and chronic hemorrhoidal disease
Antonio Brillantino, Adolfo Renzi, Pasquale Talento, Luigi Brusciano, Luigi Marano, Maurizio Grillo, Mauro Natale Maglio, Fabrizio Foroni, Alessio Palumbo, Maria Laura Sandoval Sotelo, Luciano Vicenzo, Michele Lanza, Giovanna Frezza, Massimo Antropoli, Cl
Annals of Coloproctology.2024; 40(4): 287. CrossRef - Sclerotherapy in Hemorrhoids
Anling He, Mingkai Chen
Indian Journal of Surgery.2023; 85(2): 228. CrossRef - Minimally Invasive Treatment for Advanced Hemorrhoids
Hidenori Miyamoto
Journal of the Anus, Rectum and Colon.2023; 7(1): 8. CrossRef - Mid-term outcome of a novel nonexcisional technique using aluminum potassium sulfate and tannic acid sclerotherapy with mucopexy on patients with grade III hemorrhoids
A. Tsunoda, H. Kusanagi
Techniques in Coloproctology.2023; 27(12): 1335. CrossRef - Long-term Outcomes of Aluminum Potassium Sulfate and Tannic Acid Sclerotherapy for Prolapsed Hemorrhoids: A Single-Center, Observational Study
Tatsuya Abe, Masao Kunimoto, Yoshikazu Hachiro, Kei Ohara, Mitsuhiro Inagaki
Diseases of the Colon & Rectum.2022; 65(2): 271. CrossRef - The comeback of hemorrhoidal sclerotherapy?
V. de Parades, M. Aubert, N. Fathallah, A. A. Alam, L. Spindler, P. Benfredj
Techniques in Coloproctology.2022; 26(8): 599. CrossRef - Early postoperative outcomes of a novel nonexcisional technique using aluminum potassium sulfate and tannic acid sclerotherapy with mucopexy on patients with grade III hemorrhoids
Shunya Takada, Akira Tsunoda, Tomoko Takahashi, Hiroshi Kusanagi
Annals of Coloproctology.2022; 38(4): 290. CrossRef - A Stepwise Proposal for Low-Grade Hemorrhoidal Disease: Injection Sclerotherapy as a First-Line Treatment and Rubber Band Ligation for Persistent Relapses
Roberta Tutino, Marco Massani, Leonel Jospin Kamdem Mambou, Paolina Venturelli, Immacolata Della Valle, Giuseppina Melfa, Matilde Micheli, Gaia Russo, Gregorio Scerrino, Sebastiano Bonventre, Gianfranco Cocorullo
Frontiers in Surgery.2022;[Epub] CrossRef - Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease
Pierluigi Lobascio, Rita Laforgia, Eugenio Novelli, Fabrizio Perrone, Maria Di Salvo, Angela Pezzolla, Mario Trompetto, Gaetano Gallo
Journal of Investigative Surgery.2021; 34(10): 1059. CrossRef - Medical uses for phenol in the urinary tract: A possible forgotten treatment (Review)
Takuya Sadahira, Yuki Maruyama, Toyohiko Watanabe, Takanori Sekito, Yosuke Mitsui, Koichiro Wada, Motoo Araki, Masami Watanabe
Medicine International.2021;[Epub] CrossRef - Finding possible pharmacological effects of identified organic compounds in medicinal waters (BTEX and phenolic compounds)
István Szabó, Csaba Varga
International Journal of Biometeorology.2020; 64(6): 989. CrossRef - Hämorrhoidenoperation
T. Laubert, V. Kahlke
coloproctology.2020; 42(1): 30. CrossRef - Le traitement instrumental : « Qu’en reste-t-il aujourd’hui ? »
L. Spindler, E. Pommaret, V. de Parades
Côlon & Rectum.2020; 14(1): 15. CrossRef - Effectiveness of Endoscopic Sclerotherapy with Aluminum Potassium Sulfate and Tannic Acid as a Non-Surgical Treatment for Internal Hemorrhoids
Yuichi Tomiki, Jun Aoki, Shunsuke Motegi, Rina Takahashi, Toshiaki Hagiwara, Yu Okazawa, Kosuke Mizukoshi, Masaya Kawai, Shinya Munakata, Shun Ishiyama, Kiichi Sugimoto, Kazuhiro Sakamoto
Clinical Endoscopy.2019; 52(6): 581. CrossRef - The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Hemorrhoids
Bradley R. Davis, Steven A. Lee-Kong, John Migaly, Daniel L. Feingold, Scott R. Steele
Diseases of the Colon & Rectum.2018; 61(3): 284. CrossRef - Alles beim Alten in der Hämorrhoidalchirurgie?
M. H. Roblick, S. Farke
coloproctology.2018; 40(4): 271. CrossRef - Aluminum Potassium Sulfate and Tannic Acid - A New Option for the Treatment of Grade 3 Hemorrhoids
Yong Hee Hwang
Annals of Coloproctology.2015; 31(3): 83. CrossRef
- Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis
- Inflammatory Fibroid Polyp in the Jejunum Causing Small Bowel Intussusception
- Sung Hoon Kang, Seok Won Kim, Hee Seok Moon, Jae Kyu Sung, Hyun Yong Jeong, Jin Su Kim, Gyu Sang Song
- Ann Coloproctol. 2015;31(3):106-109. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.106
- 4,202 View
- 48 Download
- 7 Web of Science
- 11 Citations
-
Abstract
PDF
Intussusceptions are defined as the telescoping of one segment of the gastrointestinal tract into an adjacent distal segment. In the small bowel, intussusceptions are typically caused by benign processes, but can occasionally be caused by inflammatory fibroid polyps, which often present as intussusception and bowel obstruction. These polyps are rare, benign, tumorous lesions in the gastrointestinal tract and are typically observed in the stomach, but can occur anywhere in the gastrointestinal tract. Any case of a jejunojejunal intussusception caused by inflammatory fibroid polyps is considered rare, and we report the case of a 51-year-old woman with an inflammatory fibroid polyp of the jejunum presenting as an intussusception who was successfully treated with a resection.
-
Citations
Citations to this article as recorded by- PÓLIPO FIBROSO INFLAMATÓRIO EM TRATO GASTROINTESTINAL, UM DIAGNÓSTICO DIFERENCIAL DE INTUSSUSCEPÇÃO INTESTINAL EM ADULTO: RELATO DE CASO E REVISÃO
Raul Valério Ponte, Priscila Ferreira de Lima e Souza, Raíra Marques Oliveira, Bruna Viana Teles Rebouças, Sarah Mombach de Arruda, Isabella Siqueira Oliveira, Kalyne Saraiva Fontenele de Araújo, Maria Eduarda Lima Lobão Maia
Revista Contemporânea.2024; 4(9): e5834. CrossRef - Jejunal Intussusception Secondary to a Large Inflammatory Fibroid Polyp: A Case Report and Discussion of Differential Diagnosis
Asma Khalid Abu-Salah, Eric Brocken, Hector Mesa, Katrina Collins, Mirella Marino
Case Reports in Pathology.2023; 2023: 1. CrossRef - Inflammatory fibroid polyp (Vanek's tumor) causing double compound ileo-ileal intussusception in an adult patient, a case report
Ahmed Gadoura, Farah Mohammed, Mohamed Abdulkarim, Ammar Ibn Yasir, Dafalla Shani, Nadir Salih
International Journal of Surgery Case Reports.2022; 93: 106947. CrossRef - Adult intussusception due to ileal polyp - A case report
Tahmina Hakim
International Journal of Surgery Case Reports.2022; 99: 107554. CrossRef - Ileal Intussusception in an Adult Caused by a Locally Invasive Inflammatory Fibroid Polyp: A Case Report
Luiz M. Nova, Paul Lopez, Clara Cerezo, Concepción Llanos, Irene Amat
Revista Española de Patología.2021; 54(1): 65. CrossRef - Adult Jejuno-jejunal intussusception due to inflammatory fibroid polyp
Yi-Kai Kao, Jian-Han Chen
Medicine.2020; 99(36): e22080. CrossRef - Adult Jejuno-Jejunal Intussusceptions due to Gastrointestinal Stromal Tumor
Jayabal Pandiaraja
Indian Journal of Medical and Paediatric Oncology.2020; 41(04): 602. CrossRef - Laparoscopic Resection of a Jejunal Inflammatory Fibroid Polyp that Caused Occult Gastrointestinal Bleeding, Diagnosed via Capsule Endoscopy and Double-Balloon Enteroscopy: A Case Report
Chizu Kameda, Hideaki Miwa, Ryohei Kawabata, Daiki Marukawa, Masahiro Murakami, Shingo Noura, Junzo Shimizu, Junichi Hasegawa
Clinical Endoscopy.2018; 51(4): 384. CrossRef - Inflammatory fibroid polyps of the appendix: different presentation and literature review
Ibrahim Albabtain, Hassan Arishi, Slava Albaghli, Jumanah Aljahani
Journal of Surgical Case Reports.2018;[Epub] CrossRef - Pólipo fibroideo inflamatorio del tracto gastrointestinal: 10 años de experiencia del Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
A.F. Romano-Munive, R. Barreto-Zuñiga, J.A. Rumoroso-García, P. Ramos-Martínez
Revista de Gastroenterología de México.2016; 81(3): 134. CrossRef - Inflammatory fibroid polyp of the gastrointestinal tract: 10 years of experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
A.F. Romano-Munive, R. Barreto-Zuñiga, J.A. Rumoroso-García, P. Ramos-Martínez
Revista de Gastroenterología de México (English Edition).2016; 81(3): 134. CrossRef
- PÓLIPO FIBROSO INFLAMATÓRIO EM TRATO GASTROINTESTINAL, UM DIAGNÓSTICO DIFERENCIAL DE INTUSSUSCEPÇÃO INTESTINAL EM ADULTO: RELATO DE CASO E REVISÃO
- Intestinal Malrotation With a Fixed Partial Volvulus in an Adult
- Youn Joon Park
- Ann Coloproctol. 2015;31(3):110-113. Published online June 30, 2015
- DOI: https://doi.org/10.3393/ac.2015.31.3.110
- 3,948 View
- 40 Download
- 1 Web of Science
- 1 Citations
-
Abstract
PDF
A 44-year-old man had been suffering from nausea, vomiting and watery diarrhea for 5 days and was then admitted to Dankook University Hospital. He had suffered from several episodes of mild symptoms, including abdominal distension, loss of appetite, easy satiety, nausea, vomiting, and diarrhea throughout his lifetime, but most episodes had been ignored by him or physicians. An upper gastrointestinal series and a computed tomography scan revealed an intestinal malrotation with a volvulus. In order to untwist the small bowel in a counterclockwise direction to about 180 degrees, we had to perform not only a dissection of Ladd's band, but also a dissection of other adhesions between the mesocolon and the mesenteric vessel trunk. Surgical intervention needs to be performed for an old intestinal malrotation with any symptoms because the structural or morphological change proceeds as time passes, which is caused by fibrosis due to tension being repetitively applied to Ladd's band, leading to its contraction. Furthermore, a severe contraction may even lead to a fixed partial volvulus.
-
Citations
Citations to this article as recorded by- Two cases of successful treatment of Ladd syndrome in adults
O.V. Zagorodniy, Yu.M. Mikhel, Yu.S. Mota, I.A. Semenyuk, V.P. Fedorenko
Acta Medica Leopoliensia.2017; 23(4): 46. CrossRef
- Two cases of successful treatment of Ladd syndrome in adults
First
Prev
TOP
